New Gene Signature for Colon Cancer Prognosis
Author Information
Author(s): Wang Shuo, Hou Sen, Jiang Shan, Wang Chao, Zhang Peipei, Ye Yingjiang, Gao Zhidong
Primary Institution: Peking University People’s Hospital, Beijing, China
Hypothesis
The study investigates the role of liquid-liquid phase separation (LLPS) in colon cancer prognosis and immune response.
Conclusion
The LLPS-related risk score (LRRS) can predict the prognosis of colon cancer patients and help identify effective immunotherapy strategies.
Supporting Evidence
- Patients with high LRRS exhibited worse prognosis and poorer response to immunotherapy.
- Two LLPS subtypes were identified with significant differences in prognosis and immune characteristics.
- LRRS was correlated with clinicopathological characteristics and genomic alterations.
Takeaway
This study found a new way to predict how well colon cancer patients will do based on certain genes that behave differently in their cancer cells.
Methodology
The study analyzed gene expression data from 1010 colon cancer samples, identifying prognostic LLPS-related differentially expressed genes and constructing a risk score using LASSO Cox regression.
Limitations
The study relied on retrospective data from public databases and lacked treatment-related information for some cohorts.
Participant Demographics
The study included colon cancer patients from the TCGA-COAD and GSE39582 cohorts, with a mix of ages and stages.
Statistical Information
P-Value
p<0.001
Confidence Interval
95% CI: 1.122-1.187
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website